Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Not yet recruiting · NCT07614282 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, post-transplant lymphoproliferative disease, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-17 | NCT07614282 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jennifer Amengual | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||